Humble Juice Co. LLC
Letter data
- Company
- Humble Juice Co. LLC
- Recipient
- Daniel Clark | Humble Juice Co. LLC | 9400 Lurline Ave | Unit B-1 | Chatsworth | , | CA | 91311 | United States | daniel@humblejuiceco.com | info@humblejuiceco.com
- Issue date
- 2021-04-09
- Posted date
- Not available
- FDA office
- Center for Tobacco Products
- Subject
- Not available
- Product
- Tobacco
- CMS ID
- 583547
- Reference number
- RW1901097
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Humble Juice Co. LLC
MARCS-CMS 583547 —
April 09, 2021
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA UPS and Electronic Mail
Reference #:
RW1901097
Product:
Tobacco
Recipient:
Recipient Name
Daniel Clark
Humble Juice Co. LLC
9400 Lurline Ave
Unit B-1
Chatsworth
,
CA
91311
United States
daniel@humblejuiceco.com
info@humblejuiceco.com
Issuing Office:
Center for Tobacco Products
United States
Dear Daniel Clark:
The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your response dated June 20, 2019, in response to our Warning Letter dated June 7, 2019. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding the Instagram account of Parker Hornday (pvrkerr), https://www.instagram.com/pvrkerr, containing social media posts with labeling and/or advertising for e-liquid products on behalf Humble Juice Co. LLC, as well as the Instagram account of Humble Juice Co. LLC (https://www.instagram.com/humblejuiceco), the Facebook account for Humble Juice Co. LLC (https://www.facebook.com/humblejuiceco), the Twitter account for Humble Juice Co. LLC (https://twitter.com/HumbleJuiceCo), and the website https://www.humblejuiceco.com.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Sincerely,
/S/
David Rice
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products
VIA Electronic Mail
Attn: Will Woodlee
wwoodlee@kkblaw.com
Content current as of:
04/26/2021
Regulated Product(s)
Tobacco